Related Experiment Video
Updated: Sep 23, 2025

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
Published on: August 4, 2016
Study of tRNA-Derived Fragment tRF-20-S998LO9D in Pan-Cancer
1Department of Blood Transfusion, The Third Xiangya Hospital of Central South University, Changsha 410013, China.
Objective:
The purpose is to study the effect of tRNA-derived fragments (tRFs) on pan-cancer through bioinformatics.
Methods:
The expression information of tRF-20-S998LO9D, a type of tRF-5, was retrieved through MINTbase in pan-cancer and verified by qPCR. We preliminarily explored the effect of tRF-20-S998LO9D on cell proliferation in breast cancer and lung cancer cell lines. Then an online KM-plotter provided by OncotRF was used to discover the prognostic significance. GO/KEGG analyses were executed to predict the potential mechanism of tRF-20-S998LO9D in cancer.
Results:
We found that tRF-20-S998LO9D was highly expressed in a variety of cancers like breast invasive carcinoma, head and neck squamous cell carcinoma, kidney renal clear cell carcinoma, lung squamous cell carcinoma, pheochromocytoma and paraganglioma, and uterine corpus endometrial carcinoma. Inhibition of tRF-20-S998LO9D led to reduced cell proliferation in breast cancer (MCF-7) and lung squamous cell carcinoma (SK-MES-1) cells. Elevated tRF-20-S998LO9D indicated poor prognosis in a variety of cancers. tRF-20-S998LO9D might be involved in multiple cancer-related pathways.
Conclusion:
We concluded that tRF-20-S998LO9D was upregulated and negatively correlated with prognosis of a variety of cancers. It may be a potential cancer-promoting marker in pan-cancer.
Insights
This study reveals that tRNA-derived fragment (tRF)-20-S998LO9D is upregulated across many cancers and linked to poor prognosis. This tRF may act as a cancer-promoting marker in pan-cancer research.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- tRNA-derived fragments (tRFs) are emerging as critical regulators in various biological processes.
- Their role in pan-cancer, however, remains largely unexplored.
- Understanding tRFs' impact is crucial for developing novel cancer biomarkers and therapeutics.
Purpose of the Study:
- To investigate the expression and prognostic significance of tRNA-derived fragment (tRF)-20-S998LO9D in pan-cancer.
- To explore the functional role of tRF-20-S998LO9D in cancer cell proliferation.
- To predict the underlying molecular mechanisms of tRF-20-S998LO9D in cancer development.
Main Methods:
- Bioinformatic retrieval of tRF-20-S998LO9D expression data from MINTbase across multiple cancer types.
- Quantitative PCR (qPCR) for expression validation.
- In vitro experiments assessing the effect of tRF inhibition on breast and lung cancer cell proliferation.
- Kaplan-Meier plotter analysis (OncotRF) for prognostic significance.
- Gene Ontology (GO) and KEGG pathway analyses for mechanism prediction.
Main Results:
- tRF-20-S998LO9D was found to be highly expressed in breast invasive carcinoma, head and neck squamous cell carcinoma, kidney renal clear cell carcinoma, lung squamous cell carcinoma, pheochromocytoma and paraganglioma, and uterine corpus endometrial carcinoma.
- Inhibition of tRF-20-S998LO9D reduced cell proliferation in MCF-7 (breast) and SK-MES-1 (lung squamous cell carcinoma) cell lines.
- Elevated tRF-20-S998LO9D levels correlated with poor prognosis in various cancers.
- tRF-20-S998LO9D is potentially involved in multiple cancer-associated pathways.
Conclusions:
- tRF-20-S998LO9D is significantly upregulated in a wide spectrum of cancers.
- Its elevated expression is negatively correlated with patient prognosis, suggesting a cancer-promoting role.
- tRF-20-S998LO9D represents a potential pan-cancer biomarker for poor prognosis.
Related Concept Videos
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
lncRNA - Long Non-coding RNAs

